vs
BIOLIFE SOLUTIONS INC（BLFS）与IRIDEX CORP（IRIX）财务数据对比。点击上方公司名可切换其他公司
BIOLIFE SOLUTIONS INC的季度营收约是IRIDEX CORP的1.3倍（$18.8M vs $14.7M），BIOLIFE SOLUTIONS INC同比增速更快（24.3% vs -69.7%），过去两年IRIDEX CORP的营收复合增速更高（11.9% vs 1.0%）
BIOLIFE SOLUTIONS INC专注于开发生物保存产品及冷链管理解决方案，服务于细胞与基因治疗、生物制药及再生医学领域，产品涵盖低温保存培养基、自动化解冻系统、温度监测工具，为全球相关企业、科研机构及临床实验室提供支持。
IRIDEX Corporation是一家全球性医疗科技企业，主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备，产品供应至北美、欧洲、亚太等地区的医疗机构与诊所，为眼部疾病治疗和医美项目提供微创解决方案。
BLFS vs IRIX — 直观对比
营收规模更大
BLFS
是对方的1.3倍
$14.7M
营收增速更快
BLFS
高出94.1%
-69.7%
两年增速更快
IRIX
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.8M | $14.7M |
| 净利润 | $11.1M | — |
| 毛利率 | — | 37.2% |
| 营业利润率 | 7.2% | — |
| 净利率 | 58.9% | — |
| 营收同比 | 24.3% | -69.7% |
| 净利润同比 | -11.1% | — |
| 每股收益（稀释后） | $0.23 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLFSIRIX
| Q4 25 | $18.8M | $14.7M | ||
| Q3 25 | $28.1M | $12.5M | ||
| Q2 25 | $25.4M | $13.6M | ||
| Q1 25 | $23.9M | $11.9M | ||
| Q4 24 | $15.1M | $12.7M | ||
| Q3 24 | $21.4M | $11.6M | ||
| Q2 24 | $19.7M | $12.6M | ||
| Q1 24 | $18.4M | $11.8M |
净利润BLFSIRIX
| Q4 25 | $11.1M | — | ||
| Q3 25 | $621.0K | $-1.6M | ||
| Q2 25 | $-15.8M | $-994.0K | ||
| Q1 25 | $-448.0K | $-1.7M | ||
| Q4 24 | $12.5M | $-834.0K | ||
| Q3 24 | $-1.7M | $-1.9M | ||
| Q2 24 | $-20.7M | $-2.7M | ||
| Q1 24 | $-10.2M | $-3.5M |
毛利率BLFSIRIX
| Q4 25 | — | 37.2% | ||
| Q3 25 | — | 32.1% | ||
| Q2 25 | — | 34.5% | ||
| Q1 25 | — | 42.5% | ||
| Q4 24 | — | 44.0% | ||
| Q3 24 | — | 37.3% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 37.9% |
营业利润率BLFSIRIX
| Q4 25 | 7.2% | — | ||
| Q3 25 | -0.3% | -11.3% | ||
| Q2 25 | -65.5% | -6.9% | ||
| Q1 25 | -5.1% | -1.7% | ||
| Q4 24 | 3.6% | -3.9% | ||
| Q3 24 | -2.0% | -16.1% | ||
| Q2 24 | -6.6% | -20.9% | ||
| Q1 24 | -17.9% | -28.0% |
净利率BLFSIRIX
| Q4 25 | 58.9% | — | ||
| Q3 25 | 2.2% | -12.6% | ||
| Q2 25 | -62.3% | -7.3% | ||
| Q1 25 | -1.9% | -14.2% | ||
| Q4 24 | 82.5% | -6.6% | ||
| Q3 24 | -8.0% | -16.7% | ||
| Q2 24 | -105.1% | -21.2% | ||
| Q1 24 | -55.4% | -29.5% |
每股收益（稀释后）BLFSIRIX
| Q4 25 | $0.23 | — | ||
| Q3 25 | $0.01 | $-0.09 | ||
| Q2 25 | $-0.33 | $-0.06 | ||
| Q1 25 | $-0.01 | $-0.10 | ||
| Q4 24 | $0.27 | $-0.05 | ||
| Q3 24 | $-0.04 | $-0.12 | ||
| Q2 24 | $-0.45 | $-0.16 | ||
| Q1 24 | $-0.22 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.0M | $6.0M |
| 总债务越低越好 | $5.0M | — |
| 股东权益账面价值 | $371.9M | — |
| 总资产 | $405.9M | $29.2M |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势，按日历期对齐
现金及短期投资BLFSIRIX
| Q4 25 | $33.0M | $6.0M | ||
| Q3 25 | $29.5M | $5.6M | ||
| Q2 25 | $31.9M | $6.8M | ||
| Q1 25 | $66.9M | $7.2M | ||
| Q4 24 | $91.5M | $2.4M | ||
| Q3 24 | $24.0M | $3.9M | ||
| Q2 24 | $22.0M | $4.1M | ||
| Q1 24 | $29.7M | $5.4M |
总债务BLFSIRIX
| Q4 25 | $5.0M | — | ||
| Q3 25 | $7.5M | — | ||
| Q2 25 | $10.1M | — | ||
| Q1 25 | $12.9M | — | ||
| Q4 24 | $15.9M | $1.0M | ||
| Q3 24 | $20.1M | $1.4M | ||
| Q2 24 | $21.1M | — | ||
| Q1 24 | $24.3M | — |
股东权益BLFSIRIX
| Q4 25 | $371.9M | — | ||
| Q3 25 | $353.7M | $4.7M | ||
| Q2 25 | $347.2M | $6.1M | ||
| Q1 25 | $352.6M | $852.0K | ||
| Q4 24 | $348.9M | $2.1M | ||
| Q3 24 | $325.5M | $2.6M | ||
| Q2 24 | $321.4M | $4.2M | ||
| Q1 24 | $333.4M | $6.5M |
总资产BLFSIRIX
| Q4 25 | $405.9M | $29.2M | ||
| Q3 25 | $392.1M | $28.4M | ||
| Q2 25 | $387.2M | $31.6M | ||
| Q1 25 | $395.1M | $34.2M | ||
| Q4 24 | $399.5M | $29.1M | ||
| Q3 24 | $381.7M | $30.2M | ||
| Q2 24 | $375.0M | $31.2M | ||
| Q1 24 | $401.6M | $34.1M |
负债/权益比BLFSIRIX
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.02× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.05× | 0.48× | ||
| Q3 24 | 0.06× | 0.53× | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.9M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.44× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BLFSIRIX
| Q4 25 | $4.9M | — | ||
| Q3 25 | $6.1M | $-1.2M | ||
| Q2 25 | $7.4M | $-397.0K | ||
| Q1 25 | $1.7M | $-1.1M | ||
| Q4 24 | $1.6M | $-1.2M | ||
| Q3 24 | $4.8M | $-3.1M | ||
| Q2 24 | $6.5M | $-1.3M | ||
| Q1 24 | $-4.5M | $-1.6M |
自由现金流BLFSIRIX
| Q4 25 | — | — | ||
| Q3 25 | — | $-1.2M | ||
| Q2 25 | — | $-410.0K | ||
| Q1 25 | — | $-1.2M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-3.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-1.7M |
自由现金流率BLFSIRIX
| Q4 25 | — | — | ||
| Q3 25 | — | -9.4% | ||
| Q2 25 | — | -3.0% | ||
| Q1 25 | — | -9.8% | ||
| Q4 24 | — | -9.8% | ||
| Q3 24 | — | -26.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -14.0% |
资本支出强度BLFSIRIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率BLFSIRIX
| Q4 25 | 0.44× | — | ||
| Q3 25 | 9.83× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
